Australia's TGA has added mental health warnings to Ozempic and other GLP-1 drugs after reports of depression and suicidal ...

Interest in the field intensified after neurologist Sue Grigson of Pennsylvania State University heard from a man who said he achieved his first ...

FDA and WHO identified semaglutide suicidal thought reports, exceeding those of other diabetes medications in their adverse ...

The most common side effects of GLP-1 medicines are related to digestion: nausea, vomiting, diarrhoea, indigestion, stomach ...

Scientists are testing whether GLP-1 drugs can help to cut cravings for cigarettes, alcohol and opioids — as well as food.

Analysis has found a link between semaglutide use and suicidal thoughts but not all evidence supports these findings ...

The rise of GLP-1 drugs such as Ozempic and Mounjaro has been nothing short of meteoric. Originally developed to treat diabetes, these drugs are now ...

The WHO’s announcement came hours after Australia released a safety alert over the potential risk of suicidal thoughts and behaviours for people using the medicines.

The Therapeutic Goods Administration issued a new warning for GLP-1 receptor agonists, including Ozempic and Mounjaro, on ...

The Australian Therapeutic Goods Administration (TGA) has updated its product warnings on the class of weight loss and ...

Alarming reports have surfaced after the national medicines watchdog disclosed information linking users of popular weight ...